| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 53.48B | 63.04B | 52.41B | 44.79B | 41.74B | 26.79B |
| Gross Profit | 33.70B | 37.78B | 33.96B | 26.86B | 23.07B | 13.34B |
| EBITDA | 32.82B | 36.47B | 32.91B | 27.23B | 24.33B | 14.79B |
| Net Income | 22.33B | 25.07B | 22.26B | 19.27B | 19.05B | 10.47B |
Balance Sheet | ||||||
| Total Assets | 239.18B | 253.28B | 227.42B | 196.33B | 186.41B | 156.91B |
| Cash, Cash Equivalents and Short-Term Investments | 31.11B | 29.70B | 31.33B | 12.72B | 7.20B | 11.16B |
| Total Debt | 30.27B | 28.25B | 33.00B | 24.95B | 39.44B | 28.55B |
| Total Liabilities | 71.78B | 74.07B | 70.37B | 57.89B | 64.31B | 52.74B |
| Stockholders Equity | 167.40B | 179.22B | 157.05B | 138.44B | 122.10B | 104.16B |
Cash Flow | ||||||
| Free Cash Flow | 6.61B | 6.00B | 14.70B | 21.33B | -29.85B | -1.38B |
| Operating Cash Flow | 8.98B | 12.36B | 21.63B | 28.10B | -23.83B | 10.69B |
| Investing Cash Flow | -4.69B | -5.57B | -23.92B | -6.44B | 11.36B | -13.90B |
| Financing Cash Flow | -5.55B | -7.71B | 2.00B | -20.34B | 7.09B | 11.42B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | ₹600.78B | 20.58 | ― | 0.48% | 15.16% | 12.66% | |
70 Outperform | ₹1.46T | 28.27 | ― | 0.86% | 2.51% | 1.05% | |
65 Neutral | $2.17B | 12.19 | 3.79% | 4.94% | 3.15% | 1.96% | |
61 Neutral | ₹882.67B | 16.77 | ― | 0.39% | 21.02% | 23.73% | |
59 Neutral | ₹148.68B | 65.64 | ― | 0.20% | 28.52% | 99.08% | |
57 Neutral | ₹42.15B | 15.74 | ― | 0.36% | 29.46% | 35.84% | |
55 Neutral | ₹522.49B | 23.95 | ― | ― | 21.54% | 24.63% |